NCT06587815

Brief Summary

This study evaluated the effect of an Ocean Wave and LED Starry Sky Projector on fatigue, sleep, and quality of life in pediatric oncology patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

9 months

First QC Date

September 3, 2024

Last Update Submit

September 4, 2024

Conditions

Keywords

fatigue, pediatric oncology, sleep, quality of life

Outcome Measures

Primary Outcomes (3)

  • Fatigue Intensity Scale Score

    The FIS is an instrument developed to measure fatigue levels by Borneman et al., 2007. A single-item scale was created to measure fatigue intensity, rated on a scale from 0 to 10, where 0 represents no fatigue and 10 represents severe, overwhelming fatigue. The scale demonstrates face and content validity, with strong concurrent validity when compared to the Revised Piper Fatigue Scale and robust criterion validity. The scale relies on self-reporting by the patient, allowing for an accurate reflection of their fatigue levels. This tool will be administered daily throughout the intervention to monitor changes in fatigue levels (Borneman et al., 2007).

    It will be evaluated every day for one month.

  • Visual Sleep Scale Score

    The primary outcome of this study will be to assess sleep quality and fatigue levels in pediatric oncology patients. The VSS is a visual tool designed to assess sleep quality in pediatric patients. The scale is scored from 1 to 10, with a higher score indicating poorer sleep quality. This scale offers a straightforward and intuitive method for evaluating the patient's perception of their sleep, making it suitable for use in a clinical setting.

    It will be evaluated every day for one month.

  • Pediatric Quality of Life Inventory (PedsQL) Score

    The PedsQL will be administered at two critical time points: at the baseline of the intervention and after one month. It is a validated tool for measuring health-related quality of life in children aged 2-18. It includes 23 items across four domains: physical health, emotional functioning, and social functioning, as defined by the World Health Organization. Additionally, it evaluates school functioning. The PedsQL provides three primary scores: Total Scale Score, Physical Health Summary Score, and Psychosocial Health Summary Score, derived from the emotional, social, and school functioning domains.

    It will be evaluated every before the study and at the end of the first month.

Study Arms (2)

Control Group

NO INTERVENTION

Children in the control group were received standard care of the clinic

Intervention Group

EXPERIMENTAL

Children in the intervention group received musical starry sky projector during the sleep time.

Other: musical starry sky projector

Interventions

Children in intervention group received musical starry sky projector during their sleep time

Intervention Group

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pediatric oncology patients aged 8-18 years.
  • Recently diagnosed (\< 1 month).
  • Active receiving chemotherapy treatment
  • Able to read and write in Turkish.
  • Willing to participate voluntarily.

You may not qualify if:

  • Being at the end of life
  • Diagnosed with mental problems.
  • Haemoglobin levels below 7 mg/dL).
  • Having visual or hearing impairments.
  • Unable to understand or communicate in Turkish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koç University

Istanbul, Fatih, 34104, Turkey (Türkiye)

Location

MeSH Terms

Conditions

ParasomniasFatigue

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 3, 2024

First Posted

September 19, 2024

Study Start

July 1, 2023

Primary Completion

April 1, 2024

Study Completion

April 30, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations